SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
4,460,428
Share change
+621,216
Total reported value
$52,853,937
Price per share
$11.85
Number of holders
51
Value change
+$6,707,329
Number of buys
32
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q2 2018

As of 30 Jun 2018, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,460,428 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., TIEDEMANN ADVISORS, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, AXA, PARSONS CAPITAL MANAGEMENT INC/RI, Morse Asset Management, Inc, STATE STREET CORP, and Sectoral Asset Management Inc. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.